相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical and immunologic responses to a novel in situ lymphoma vaccine maneuver: Preliminary results of a phase II trial of intra-tumoral CpG 7909
J. Brody et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Jason D. Fontenot et al.
JOURNAL OF IMMUNOLOGY (2017)
T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy
Roch Houot et al.
BLOOD (2009)
Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols
Daphne de Jong et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Mechanisms of Foxp3+ T Regulatory Cell-Mediated Suppression
Ethan M. Shevach
IMMUNITY (2009)
被撤回的出版物: Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications (a study from the Lunenburg Lymphoma Biomarker Consortium) (Retracted article. See vol. 65, pg. 861, 2012)
D. de Jong et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
Local and systemic induction of CD4+CD25+ regulatory T-cell population by non-Hodgkin lymphoma
Sajjan Mittal et al.
BLOOD (2008)
Activation of natural regulatory T cells by IgG Fc-derived peptide Tregitopes
Anne S. De Groot et al.
BLOOD (2008)
Depletion of CD4+ CD25+ regulatory T cells inhibits local tumour growth in a mouse model of B cell lymphoma
I. Heier et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
Alexandar Tzankov et al.
HAEMATOLOGICA (2008)
High numbers of tumor-associated macrophages have an adverse prognostic value that can be circumvented by rituximab in patients with follicular lymphoma enrolled onto the GELA-GOELAMS FL-2000 trial
Danielle Canioni et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma
Abdulwahab J. Al-Tourah et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages
Machteld M. Tiemessen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
CD70+ non-Hodgkin lymphoma B cells induce Foxp3 expression and regulatory function in intraturnoral CD4+CD25- T cells
Zhi-Zhang Yang et al.
BLOOD (2007)
A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone
Minna Taskinen et al.
CLINICAL CANCER RESEARCH (2007)
Follicular lymphoma intratumoral CD4(+)CD25(+)GITR(+) regulatory T cells potently suppress CD3/CD28-costimulated autologous and allogeneic CD8(+)CD25(-) and CD4(+)CD25(-) T cells
Shannon P. Hilchey et al.
JOURNAL OF IMMUNOLOGY (2007)
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma
Joaquim Carreras et al.
BLOOD (2006)
Attenuation of CD8+ T-cell function by CD4+CD25+ regulatory T cells in B-cell non-Hodgkin's lymphoma
Zhi-Zhang Yang et al.
CANCER RESEARCH (2006)
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma
ZZ Yang et al.
BLOOD (2006)
FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma
G Roncador et al.
LEUKEMIA (2005)
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3+CD25+CD4+ regulatory T cells
K Ko et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cutting edge:: Direct suppression of B cells by CD4+CD25+ regulatory T cells
HW Lim et al.
JOURNAL OF IMMUNOLOGY (2005)
Analysis of multiple biomarkers, shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL)
P Farinha et al.
BLOOD (2005)
CD4+ CD25+ regulatory T cells control the induction of antigen-specific CD4+ helper T cell responses in cancer patients
H Nishikawa et al.
BLOOD (2005)
Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity
B Bienvenu et al.
JOURNAL OF IMMUNOLOGY (2005)
Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self
S Sakaguchi
NATURE IMMUNOLOGY (2005)
Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment
AM Glas et al.
BLOOD (2005)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
SS Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
CP Hans et al.
BLOOD (2004)
Autoreactive T cells in healthy individuals
NA Danke et al.
JOURNAL OF IMMUNOLOGY (2004)
CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses
H Nishikawa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
CD4+CD25+ regulatory T cells in patients with gastrointestinal malignancies -: Possible involvement of regulatory T cells in disease progression
T Sasada et al.
CANCER (2003)
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
An essential role for Scurfin in CD4+CD25+ T regulatory cells
R Khattri et al.
NATURE IMMUNOLOGY (2003)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
JD Fontenot et al.
NATURE IMMUNOLOGY (2003)
Control of regulatory T cell development by the transcription factor Foxp3
S Hori et al.
SCIENCE (2003)
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma
UK Liyanage et al.
JOURNAL OF IMMUNOLOGY (2002)
Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25+ regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses
RPM Sutmuller et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Regulatory T cells: Key controllers of immunologic self-tolerance
S Sakaguchi
CELL (2000)
分享论文
